Bizarre Patents
Ballistic resistant body covering
A ballistic resistant body covering for protecting the torso, groin and neck area from ballistic missiles.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6258783 | Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride Pharmaceutical compositions in the form of an emulsion preconcentrate or microemulsion preconcentrate which comprise a cyclosporin as active ingredient, acetylated monoglyceride as lipophilic solvent, a surfactant, and optionally a hydrophilic solvent.... | 07/10/2001 |
| 6218373 | Formulations containing hyaluronic acid A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or con... | 04/17/2001 |
| 6197335 | Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant A solid pharmaceutical composition for oral administration comprising a cyclosporin and an anionic surfactant, preferably sodium lauryl sulfate, wherein the amount of anionic surfactant is at least about forty percent of the minimum amount needed to disso... | 03/06/2001 |
| 6194392 | Treatment of conditions and disease A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 02/27/2001 |
| 6140312 | Formulations containing hyaluronic acid The invention relates to a method of rapidly transporting a drug to the epidermis and accumulating and maintaining the drug therein for a prolonged period of time comprising administration of a therapeutically efective non-toxic amount of the drug with an... | 10/31/2000 |
| 6136793 | Formulations containing hyaluronic acid A method of treating a disease or condition comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said dis... | 10/24/2000 |
| 6132286 | Preparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromide A process is provided for the preparation of 1,2,5,6-tetrahydro-3-carboalkoxypyridines of formula (III) ##STR1## wherein R is a straight or cyclic substituted or unsubstituted alkyl chain having 1 to 6 carbon atoms, phenyl C1-6 alkyl, ment... | 10/17/2000 |
| 6123094 | Single lever valve and cartridge with integral mixing chamber and divided waterway A valve assembly is provided including a housing having an opening wherein a cartridge is inserted. The housing has axially aligned inlets and outlets for hot and cold water. The cartridge includes a stationary sleeve containing a rotatable stem member. T... | 09/26/2000 |
| 6120871 | Loading dock bumpers A loading dock bumper comprising: (a) a first rigid part for fastening to said dock (b) a second rigid part engaged with said first rigid part by at least one connecting device, said second rigid part being moveable with respect to said first rigid part betwee... | 09/19/2000 |
| 6107490 | Process for the manufacture of 4-methyl-5-hydroxymethyl-imidazole A process is provided for the manufacture of 4-lower-alkyl-5-hydroxymethyl-imidazole comprising reacting (4)-lower-alkyl imidazole with formaldehyde in an alkanol solvent having from 2 to 5 carbon atoms in the presence of a solid mild base suspended in ... | 08/22/2000 |
| 6103704 | Therapeutic methods using hyaluronic acid A method of accumulating a drug and a form of hyaluronic acid in the skin and/or exposed tissue of a human includes topically administering a therapeutically effective dosage amount of a formulation which comprises at least 5 mg/cm2 of the form... | 08/15/2000 |
| 6087344 | Formulations containing hyaluronic acid Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical applic... | 07/11/2000 |
| 6083935 | Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis A peritoneal dialysis solution consisting essentially of an effective amount of N-acetylglucosamine and electrolytes.... | 07/04/2000 |
| 6080860 | Methods of making ureas and guanidines including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor Novel methods for the synthesis of substituted ureas and guanidines including Terazosin, Prazosin, Doxazosin, Tiodazosin, Trimazosin, Quinasin and Bunazosin (exemplary of 2-amino substituted Quinazolines), Meobentine and Bethanidine and novel intermediate... | 06/27/2000 |
| 6069135 | Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents A pharmaceutical composition is provided comprising: (1) an agent selected from a medicinal agent and a therapeutic agent and combinations thereof in a therapeutically effective amount to treat a disease or condition in humans who will benefit from the treatme... | 05/30/2000 |
| 6048844 | Treatment of conditions and disease A combination for administration to a mammal which combination employes a therapeutically effective amount of medicinal and/or therepeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, analo... | 04/11/2000 |
| 5990096 | Formulations containing hyaluronic acid The invention relates to a method of controlling the unloading of a drug from the skin or exposed tissue of a human into the lymphatic system comprising transporting an effective dosage amount of the drug into the skin or exposed tissue by an effective no... | 11/23/1999 |
| 5990095 | Use of hyaluronic acid and forms to prevent arterial restenosis This invention relates to a method of inhibiting the narrowing of the tubular walls of an animal with a form of hyaluronic acid.... | 11/23/1999 |
| 5985850 | Compositions comprising hyaluronic acid and drugs A dosage amount of a pharmaceutical composition comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid, wherein the form of h... | 11/16/1999 |
| 5985851 | Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof A method of detoxifying a patient by peritoneal dialysis which patient will benefit from peritoneal dialysis treatment by involving underperfused or pathological tissue the administration of an agent suitable for peritoneal dialysis treatment, comprising ... | 11/16/1999 |
| 5977088 | Formulations containing hyaluronic acid Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical applic... | 11/02/1999 |
| 5972906 | Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof A method for the treatment of mucous membrane trauma disease or condition for the relief of pain associated therewith comprising administering topically an effective amount of a composition comprising an N.S.A.I.D. and a form of hyaluronic acid selected f... | 10/26/1999 |
| 5962689 | Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds This invention relates to new stereoselective processes for preparing 3-substituted-4-aryl piperidines and methods for controlling the absolute stereochemistry at the C-3 and C-4 positions of the piperidine ring. Compounds of this type are key intermediat... | 10/05/1999 |
| 5962433 | Topical composition containing hyaluronic acid and NSAIDS A pharmaceutical composition is provided comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology and/or trauma of skin and/or exposed tissue of a human patient in need of treatment ... | 10/05/1999 |
| 5942498 | Formulations containing hyaluronic acid Topically applied transdermally quick penetrating compositions containing a drug and hyaluronic acid and/or salts thereof and methods of treating diseases and conditions employing said compositions.... | 08/24/1999 |
| 5932560 | Treatment of conditions and disease A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 08/03/1999 |
| 5929048 | Treatment of conditions and disease A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 07/27/1999 |
| 5919931 | Process for the manufacture of intermediates suitable to make doxazosin, terazosin, prazosin, tiodazosin and related antihypertensive medicines A process is provided for the manufacture of: where R is: ##STR1## comprising reacting: ##STR2## wherein R1 may be selected from H, Methyl, Ethyl and suitable lower alkyl groups, Cn H2n+1 (where n is from 3 to 5)... | 07/06/1999 |
| 5914314 | Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 06/22/1999 |
| 5914322 | Treatment of disease and conditions A topically applied transdermally penetrating systemic independent acting pharmaceutical combination and formulation for the treatment of a disease or condition of the skin and exposed tissue for example, basal cell carcinoma, the precancerous, often recu... | 06/22/1999 |
| 5910489 | Topical composition containing hyaluronic acid and NSAIDS A pharmaceutical composition comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology and/or trauma of skin and/or exposed tissue of a human patient in need of treatment suffering fr... | 06/08/1999 |
| 5908959 | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof A process is provided for the preparation of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof which comprises of: a) reacting 4-aminobutyric acid with phosphorous acid and phosphorus trichloride in the presence of a polyalkylene(glycol)... | 06/01/1999 |
| 5872258 | Commercial process for the manufacture of fluconazole and intermediates useful in the manufacture thereof A process for making Fluconazole is provided comprising carrying out the following scheme of reaction: ##STR1##... | 02/16/1999 |
| 5852002 | Treatment of conditions and disease A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 12/22/1998 |
| 5847002 | Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID The use of: (a) a non-steroidal anti-inflammatory agent, and (b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of hyaluronic acid, in the manufacture of a pharmaceutical composition f... | 12/08/1998 |
| 5834444 | Hyaluronic acid and salts thereof inhibit arterial restenosis A method is provided of preventing arterial restenosis of an animal after the arteries have been traumatized. The method comprises the administration of a therapeutically effective non-toxic amount of hyaluronic acid and/or pharmaceutically acceptable sal... | 11/10/1998 |
| 5830882 | Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, anal... | 11/03/1998 |
| 5824658 | Topical composition containing hyaluronic acid and NSAIDS A method of treating pain topically, said method comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage amount comprising (1) a non-steroidal anti-inflammatory drug (NSAID)... | 10/20/1998 |
| 5817642 | Clearing of atherosclerosis A method of clearing atherosclerosis comprising the step of administering to a patient, at least one dosage amount of a pharmaceutical composition comprising an effective non-toxic amount of each of a chelating agent, a non-steroidal anti-inflammatory dru... | 10/06/1998 |
| 5817644 | Targeting of dosages of medicine and therapeutic agents A method of treating a disease or condition in a human treatable by a medicine and/or therapeutic agent which may be transported by an agent to the site in need of treatment in the body and which agent may also transport the medicine and/or therapeutic ag... | 10/06/1998 |
